Last updated: August 17, 2026

Examiner: VYAS, KEYUR ANILKUMAR

Tech Center 1600 • Art Units: 1600 1635 1637 1654 1682

This examiner grants 52% of resolved cases

Performance Statistics

52.1%

Allow Rate

-7.9% vs TC avg

119

Total Applications

+64.0%

Interview Lift

1333

Avg Prosecution Days

Based on 73 resolved cases, 2023–2026

5.6%

§101 Eligibility

18.0%

§102 Novelty

34.2%

§103 Obviousness

26.5%

§112 Clarity

App #	Title	Status	Assignee
17846636	NOVEL RNA THERAPEUTICS AND USES THEREOF	Non-Final OA	Eli Lilly and Company
18567763	GENE THERAPY FOR DUCHENNE MUSCULAR DYSTROPHY	Non-Final OA	University of Florida Research Foundation, Incorporated
17078627	METHODS FOR TREATING PARKINSON'S DISEASE	Final Rejection	Korea Advanced Institute of Science and Technology
17281049	METHODS FOR PREVENTING AND TREATING PULMONARY INFLAMMATION AND FIBROSIS	Final Rejection	UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC.

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.